FDA extends Plavix patent by 6 months to May 2012
Tuesday, January 25, 2011 - 15:32
in Health & Medicine
(AP) -- The makers of Plavix, the world's second best-selling medication, said Tuesday they will retain exclusive U.S. marketing rights to the blood thinner for an additional six months, under a decision by U.S. health regulators.